segmented based on route of drug administration into Injection and Oral. The injection segment is accounted
for the most preferred route of drug administration as it results in quick drug delivery.
Make an Enquiry
https://www.infiniumglobalresearch.com/reports/enquiry/85
Geographic Coverage and Analysis:
The report provides regional analysis covering geographies such as North America, Europe, Asia Pacific, Latin
America and Rest of the World (RoW). Asia pacific is accounted for the largest share of market in the global
cephalosporin drugs market. Asia Pacific continued its dominance by covering more than 50% market share
between 2014 and 2017. Increasing demand for highly developed healthcare infrastructure, increasing
awareness about cephalosporin’s drugs among the patients and benefits associated with it are expected to be
the key factors supporting the growth of this region over the forecast period. North America is considered to
be the most attractive market by region over the forecast period and anticipated to grow at the highest CAGR
due to rising prevalence in infectious diseases in the region.
Companies Profiled:
The companies covered in the report include
Allergan, Astellas,
Bristol-Myers Squibb,
GSK,
Merck,
Abbott,
Aspen Pharmacare,
AstraZeneca,
Johnson & Johnson,
Infinium Global Research